Connie Choi
Psychiatry · Chicago, ILNPI 1366534398
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 160 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. 17 manufacturers reported payments, led by ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) at 25.2% of the total. 2025 is the largest year on record at $1,616, 4.8 times the $335 reported in 2019.
Across 160 payments — averaging $23.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$956
- AbbVie$803
- Lundbeck LLC$535
- Otsuka America Pharmaceutical, Inc.$368
- Johnson & Johnson$297
- Takeda Pharmaceuticals U.S.A., Inc.$269
- plus $557 from 11 others
What the payments were for
- Food & beverage$3,786100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 31 | $956 |
| AbbVie | 32 | $803 |
| Lundbeck LLC | 27 | $535 |
| Otsuka America Pharmaceutical, Inc. | 18 | $368 |
| Johnson & Johnson | 14 | $297 |
| Takeda Pharmaceuticals U.S.A., Inc. | 13 | $269 |
| Axsome Therapeutics, Inc. | 5 | $127 |
| Vanda Pharmaceuticals Inc. | 3 | $77 |
| Corium, LLC | 2 | $63 |
| Supernus Pharmaceuticals, Inc. | 3 | $63 |
| OWP Pharmaceuticals, Inc. | 3 | $56 |
| TMS Neurohealth Centers Inc. | 1 | $43 |
| Idorsia Pharmaceuticals US Inc | 2 | $35 |
| Avanir Pharmaceuticals, Inc. | 2 | $31 |
| Ironshore Pharmaceuticals Inc. | 2 | $30 |
| Noven Therapeutics, LLC | 1 | $17 |
| Sage Therapeutics, LLC | 1 | $15 |
How this compares
$3,786 in reported general payments places this provider in the 85th percentile of 1,344 psychiatry providers in Illinois.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Escitalopram Oxalate | 14 | $249 |
| Trazodone Hcl | 24 | $208 |
| Bupropion XlBupropion Hcl | 11 | $173 |
| Duloxetine Hcl | 12 | $142 |
| Imipramine Hcl | 12 | $113 |
| Zolpidem Tartrate | 11 | $46 |
Paid to pharmacies, not to this prescriber.
Other psychiatry in Chicago
- Mitchell GlaserChicago$752K
- Peter WeidenChicago$440K
- Michelle DeesChicago$289K
- Jeffrey RadoChicago$208K
- K Ranga KrishnanChicago$92K
- Richard BaerChicago$44K
- Adam GoldenbergChicago$23K
- Olusola AjiloreChicago$21K
- Emil CoccaroChicago$20K
- Guarava AgarwalChicago$20K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.